Word

Status

Pending

Status Code

686

Status Date

Tuesday, July 30, 2024

Serial Number

79346632

Mark Type

2

Filing Date

Friday, May 20, 2022

Published for Opposition

Tuesday, July 30, 2024

Trademark Owner History

Albumedix Ltd - Owner At Publication

Classifications

41 Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services

45 Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services

42 Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific, chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for the aforementioned services

The mark consists of a red hexagon with curved corners. The hexagon has a portion of its center and bottom left edge removed in the shape that resembles an albumin protein. The color white represents background and is not part of the mark.
The color(s) red is/are claimed as a feature of the mark.

Trademark Events

Mar 7, 2023

Assigned To Examiner

Aug 4, 2022

Sn Assigned For Sect 66a Appl From Ib

Aug 5, 2022

New Application Office Supplied Data Entered

Aug 9, 2022

Application Filing Receipt Mailed

Jan 29, 2023

New Representative At Ib Received

Mar 15, 2023

Non-Final Action Written

Mar 16, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Apr 2, 2023

New Representative At Ib Received

May 4, 2023

Refusal Processed By Mpu

May 4, 2023

Non-Final Action Mailed - Refusal Sent To Ib

May 24, 2023

Refusal Processed By Ib

Nov 3, 2023

Teas Response To Office Action Received

Nov 3, 2023

Correspondence Received In Law Office

Nov 3, 2023

Teas/Email Correspondence Entered

Dec 31, 2023

Final Refusal Written

Dec 31, 2023

Final Refusal E-Mailed

Dec 31, 2023

Notification Of Final Refusal Emailed

Jan 10, 2024

Notification Of Possible Opposition Sent To Ib

Jan 10, 2024

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 29, 2024

Notification Of Possible Opposition - Processed By Ib

Jun 24, 2024

Correspondence Received In Law Office

Jun 24, 2024

Teas/Email Correspondence Entered

Jun 24, 2024

Teas Request For Reconsideration Received

Jun 25, 2024

Approved For Pub - Principal Register

Jul 10, 2024

Notification Of Notice Of Publication E-Mailed

Jul 30, 2024

Published For Opposition

Jul 30, 2024

Official Gazette Publication Confirmation E-Mailed